About 1 result found for searched term "Bimagrumab" (0.192 seconds)
Cat.No. | Name | Target |
---|---|---|
M24625 | Bimagrumab | TGF-beta/Smad |
BYM338 | ||
Bimagrumab (BYM338) is a human monoclonal antibody that blocks activin type II receptor (ActRII), with KDs of 1.7 pM and 434 pM for human ActRIIB and ActRIIA, respectively. Bimagrumab can be used for the research of pathological muscle loss and weakness. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.